103.36
+0.79(+0.77%)
Currency In USD
| Previous Close | 102.57 |
| Open | 102.97 |
| Day High | 106.6 |
| Day Low | 102.51 |
| 52-Week High | 139.13 |
| 52-Week Low | 72.21 |
| Volume | 904,364 |
| Average Volume | 738,200 |
| Market Cap | 5.09B |
| PE | -17.91 |
| EPS | -5.77 |
| Moving Average 50 Days | 106.67 |
| Moving Average 200 Days | 102.79 |
| Change | 0.79 |
If you invested $1000 in Axsome Therapeutics, Inc. (AXSM) since IPO date, it would be worth $11,826.09 as of June 28, 2025 at a share price of $103.36. Whereas If you bought $1000 worth of Axsome Therapeutics, Inc. (AXSM) shares 5 years ago, it would be worth $1,353.59 as of June 28, 2025 at a share price of $103.36.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
Axsome Therapeutics Champions Brain Health During Alzheimer's & Brain Awareness Month
GlobeNewswire Inc.
Jun 20, 2025 11:00 AM GMT
NEW YORK, June 20, 2025 (GLOBE NEWSWIRE) -- Axsome Therapeutics, Inc. (NASDAQ: AXSM), a biopharmaceutical company leading a new era in the treatment of central nervous system (CNS) disorders, today is joining with the Alzheimer’s disease advocacy c
Axsome Therapeutics to Present Data Spanning the SYMBRAVO® (meloxicam and rizatriptan) Clinical Program at the 67th Annual Scientific Meeting of the American Headache Society (AHS)
GlobeNewswire Inc.
Jun 18, 2025 11:00 AM GMT
NEW YORK, June 18, 2025 (GLOBE NEWSWIRE) -- Axsome Therapeutics, Inc. (NASDAQ: AXSM), a biopharmaceutical company leading a new era in the treatment of central nervous system (CNS) disorders, today announced that data from across the SYMBRAVO® (mel
Axsome Therapeutics Proudly Supports Migraine and Headache Awareness Month Alongside the Association of Migraine Disorders
GlobeNewswire Inc.
Jun 16, 2025 11:00 AM GMT
NEW YORK, June 16, 2025 (GLOBE NEWSWIRE) -- Axsome Therapeutics, Inc. (NASDAQ: AXSM), a biopharmaceutical company leading a new era in the treatment of central nervous system (CNS) disorders, is proud to recognize Migraine and Headache Awareness Mo